Meta’s executives will meet in a Delaware court starting Wednesday over a lawsuit filed by three minority shareholders who ...

Drugs like semaglutide, also known by the brand names Ozempic and Wegovy, have transformed how we treat obesity, but soaring demand has led to frequent supply shortages. In the US ...

CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.

The first trial of oversight liability claims against a public company may prove riskier for Delaware’s elite business court ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Signing into law the other criminal justice bill, named the Law and Order Act, Stein praised the effort by lawmakers to ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The most important philosophy we have of AI is that AI will never make decisions. Period. So AI would help us collect the ...

CVS is set to drop Zepbound as a medicine, but will continue to carry other popular weight loss drugs instead.

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...